UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors

PloS one, 2016-04, Vol.11 (4), p.e0154038-e0154038

2016

Link zum Volltext

Verfügbarkeit prüfen

A role for procarboxypepidase U (TAFI) in thrombosis

Frontiers in bioscience, 2007-01, Vol.12, p.1973

2007

Link zum Volltext

Verfügbarkeit prüfen

Measurement of Procarboxypeptidase U (TAFI) in Human Plasma: A Laboratory Challenge

Clinical chemistry (Baltimore, Md.), 2006-01, Vol.52 (1), p.30-36

2006

Link zum Volltext

Verfügbarkeit prüfen

Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma

Analytical biochemistry, 2010, Vol.396 (1), p.152-154

2010

Link zum Volltext

Verfügbarkeit prüfen

The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays

Analytical biochemistry, 2006-09, Vol.356 (1), p.157-159

2006

Link zum Volltext

Verfügbarkeit prüfen

Major carboxypeptidase N deficiency

Clinica chimica acta, 2008-03, Vol.389 (1-2), p.181-182

2008

Link zum Volltext

Verfügbarkeit prüfen

Chloral hydrate intoxication in a 3-month-old child: Avoidance of hemodialysis by an immediate determination of trichloroethanol

Clinical biochemistry, 2010-02, Vol.43 (3), p.328-330

2010

Link zum Volltext

Verfügbarkeit prüfen

Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: Development of highly selective CPU substrates as useful tools for assay development

Clinica chimica acta, 2008-01, Vol.387 (1-2), p.158-160

2008

Link zum Volltext

Verfügbarkeit prüfen

Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate

Analytical biochemistry, 2005-05, Vol.340 (1), p.106-112

2005

Link zum Volltext

Verfügbarkeit prüfen

The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over

Biochimica et biophysica acta, 2007-02, Vol.1774 (2), p.267-277

2007

Link zum Volltext

Verfügbarkeit prüfen

Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients

Clinical neurology and neurosurgery, 2009-02, Vol.111 (2), p.165-170

2009

Link zum Volltext

Verfügbarkeit prüfen

Quality control of total carbon dioxide (CO 2 ) in serum or plasma using the Abbott Architect is affected by environmental pCO 2 concentrations

Annals of clinical biochemistry, 2023-01, Vol.60 (1), p.46

2023

Link zum Volltext

Verfügbarkeit prüfen

A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation

Clinica chimica acta, 2006-09, Vol.371 (1), p.124-129

2006

Link zum Volltext

Verfügbarkeit prüfen

Impacts of the SADC Free Trade Agreement on South African Agricultural Trade

Outlook on agriculture, 2014-03, Vol.43 (1), p.53-59

2014

Link zum Volltext

Verfügbarkeit prüfen

An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis

Frontiers in bioscience (Landmark. Print), 2011-06, Vol.16 (7), p.2427-2450

2011

Link zum Volltext

Verfügbarkeit prüfen

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

Journal of thrombosis and haemostasis, 2009-12, Vol.7 (12), p.1962-1971

2009

Link zum Volltext

Verfügbarkeit prüfen

Influence of separator gel in Sarstedt S-Monovette® serum tubes on various therapeutic drugs, hormones, and proteins

Clinica chimica acta, 2012-01, Vol.413 (1-2), p.100-104

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the long-term effectiveness of crop insurance products to provide cost effective and constant cover for maize producers under stochastic yields and prices

Agrekon, 2017-07, Vol.56 (3), p.233-247

2017

Link zum Volltext

Verfügbarkeit prüfen

Estimating The Maximum Value of Crop Hail Insurance Under Stochastic Yield and Price Risk

Agrekon, 2015-01, Vol.54 (4), p.28-44

2015

Link zum Volltext

Verfügbarkeit prüfen

Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia

Thrombosis research, 2009-09, Vol.124 (4), p.427-432

2009

Link zum Volltext

Verfügbarkeit prüfen

Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down‐regulating fibrinolysis

The FEBS journal, 2006-02, Vol.273 (4), p.778-792

2006

Link zum Volltext

Verfügbarkeit prüfen

Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages

Clinica chimica acta, 2009-03, Vol.401 (1), p.158-161

2009

Link zum Volltext

Verfügbarkeit prüfen

Ethanol dependence of α1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases

Transfusion (Philadelphia, Pa.), 2008-02, Vol.48 (2), p.314-320

2008

Link zum Volltext

Verfügbarkeit prüfen

Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis

Srpski arhiv za celokupno lekarstvo, 2010-01, Vol.138 Suppl 1 (suppl. 1), p.74-78

2010

Link zum Volltext

Verfügbarkeit prüfen

Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases

Transfusion (Philadelphia, Pa.), 2008-02, Vol.48 (2), p.314-320

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(49)
Berichte
(1)

Sprache

Englisch
(50)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Validation and Application of a Custom-Designed Targeted Next-Generation Sequencing Panel for the Diagnostic Mutational Profiling of Solid Tumors

A role for procarboxypepidase U (TAFI) in thrombosis

Measurement of Procarboxypeptidase U (TAFI) in Human Plasma: A Laboratory Challenge

Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma

The intrinsic enzymatic activity of plasma procarboxypeptidase U (TAFI) can interfere with plasma carboxypeptidase N assays

Major carboxypeptidase N deficiency

Chloral hydrate intoxication in a 3-month-old child: Avoidance of hemodialysis by an immediate determination of trichloroethanol

Comparative substrate specificity study of carboxypeptidase U (TAFIa) and carboxypeptidase N: Development of highly selective CPU substrates as useful tools for assay development

Development of a fast kinetic method for the determination of carboxypeptidase U (TAFIa) using C-terminal arginine containing peptides as substrate

The role of the S1 binding site of carboxypeptidase M in substrate specificity and turn-over

Carboxypeptidase U (TAFIa) decreases the efficacy of thrombolytic therapy in ischemic stroke patients

Quality control of total carbon dioxide (CO 2 ) in serum or plasma using the Abbott Architect is affected by environmental pCO 2 concentrations

A rapid and sensitive assay for the quantitation of carboxypeptidase N, an important regulator of inflammation

Impacts of the SADC Free Trade Agreement on South African Agricultural Trade

An update on the role of carboxypeptidase U (TAFIa) in fibrinolysis

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

Influence of separator gel in Sarstedt S-Monovette® serum tubes on various therapeutic drugs, hormones, and proteins

Evaluating the long-term effectiveness of crop insurance products to provide cost effective and constant cover for maize producers under stochastic yields and prices

Estimating The Maximum Value of Crop Hail Insurance Under Stochastic Yield and Price Risk

Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia

Limited mutagenesis increases the stability of human carboxypeptidase U (TAFIa) and demonstrates the importance of CPU stability over proCPU concentration in down‐regulating fibrinolysis

Procarboxypeptidase U (TAFI) and the Thr325Ile proCPU polymorphism in patients with hereditary mucocutaneous hemorrhages

Ethanol dependence of α1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases

Thrombin activatable fibrinolysis inhibitor (TAFI): a molecular link between coagulation and fibrinolysis

Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases

Suchergebnisse filtern